Antithrombotic therapy in patients with coronary artery disease and atrial fibrillation with increasing CHA₂DS₂-VASc score.

<p>Any antiplatelet therapy alone (single or dual) is therefore: ^a 1,178 (52.8%), ^b 130 (69.5%), ^c 542 (56.4%), ^d 505 (46.9%). Abbreviations: AP, antiplatelet; OAC, oral anticoagulant.